Nanobiotix is trading 5.40% higher at $22.43, with no confirmed company-specific catalyst identified for October 15, 2026.
- A market snapshot also reported no new macro, sector or company-specific catalyst for the stock that day.
- The broader biotech sector was up 2.20%, offering supportive context but not establishing a direct cause for Nanobiotixβs larger gain.